Author:
Bohr Anna-Helene,Nielsen Susan,Müller Klaus,Karup Pedersen Freddy,Andersen Lars Bo
Publisher
Springer Science and Business Media LLC
Subject
Immunology and Allergy,Rheumatology,Pediatrics, Perinatology, and Child Health
Reference34 articles.
1. Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, et al. Ongoing disease activity and changing categories in a long-term Nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum. 2011;63(9):2809–18.
2. Minden K, Niewerth M, Zink A, Seipelt E, Foeldvari I, Girschick H, et al. Long-term outcome of patients with JIA treated with Etanercept, results of the biologic register JuMBO. Rheumatology. 2012;51(8):1407–15. doi: 10.1093/rheumatology/kes019 .
3. Bertilsson L, Anderson-Gäre B, Fasth A, Petersson IF, Forsblad-D’elia H. Disease course, outcome, and predictors of outcome in a population-based juvenile chronic arthritis cohort followed for 17 years. J Reumatol. 2013;40(5):715–24.
4. Selvaag AM, Aulie HA, Lilleby V, Flatø B. Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis. Ann Rheum Dis. 2014;0:1–6.
5. Breda L, Di Marzio D, Giannini C, Gaspari S, Nozzi M, Scarinci A et al. Relationship between inflammatory markers, oxidant-antioxidant status and intima-media thickness in prepubertal children with juvenile idiopathic arthritis. Clin.Res.Cardiol. 2012. doi: 10.1007/s00392-012-0496-3 .
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献